Journal of Ocular Pharmacology and Therapeutics

Proteomic Profile Analysis of Plasma and Aqueous Humor from Glaucoma and Nonglaucomatous Patients

By Pessuti CL, Huang CL, Banks A et al.

Study in peopleBiomarkers
Follow

Abstract

PURPOSE: Glaucoma, a multifactorial ocular neuropathy, can lead to irreversible vision loss. Diagnosis involves assessing optic cupping (increased cup-to-disc ratios) and structural changes (like retinal nerve fiber layer thinning) through clinical imaging. Elevated intraocular pressure (IOP) is commonly associated with glaucoma but is not universally present. However, understanding disease progression is hindered by limited access to donor ocular tissue and consistent clinical data. We hypothesized that the proteomes of aqueous humor (AH) and plasma may be altered in disease and correlate with clinical parameters such as IOP and cup-to-disc ratios. METHODS: AH and plasma samples were collected from 36 glaucoma patients (17 male, 19 female) and 35 nonglaucomatous control patients (16 male, 19 female) undergoing cataract surgery. Protein profiles was compared using the SOMAscan® assay system for proteome profiling. From glaucomatous donors, correlations between IOP and cup-to-disc ratios to proteome differences were determined. RESULTS: Overall proteomics profiles between both AH and plasma were compared by combining all samples (glaucoma and nonglaucoma) and then performing correlation analyses. This study revealed similar protein abundance in the two biological fluids. Additionally, it identified different abundance of proteins in plasma and AH between glaucoma and nonglaucoma samples. The differential proteins identified were involved in pathways related to vascular integrity, inflammation, immune response, cell adhesion, and complement activation. Generally, glaucomatous AH showed higher protein levels. Neurofilament light chain protein correlated with elevated IOP and inflammatory markers but not with cup-to-disc ratio. CONCLUSIONS: Together, our data demonstrate that the proteins identified in this study from glaucomatous donors correspond to markers of neurodegeneration and those that may inhibit cell proliferation or disrupt vascular integrity.

The paper

Pessuti CL, Huang CL, Banks A et al.

Journal of Ocular Pharmacology and Therapeutics, 7 Jul 2026

doi.org/10.1177/10807683261460687PubMed 42415469